- Home
- A-Z Publications
- Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics)
- Previous Issues
- Volume 20, Issue 1, 2023
Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics) - Volume 20, Issue 1, 2023
Volume 20, Issue 1, 2023
-
-
Papillary Thyroid Carcinoma: A Narrative Review on the Most Important Genetic and Epigenetic Alterations
Authors: Atiyeh Mohammadi, Seyyed Amir Y. Ahmadi and Reza NekouianPapillary Thyroid Carcinoma (PTC) is the most common subtype of thyroid cancer that is the most prevalent one in the endocrine system. According to worldwide reports, its prevalence rate has been increasing in recent decades. The Discovery of DNA sequencing methods and molecular diagnostic techniques provides an insight into the understanding of PTC molecular biology and as well as in thyroidology, which opens a Read More
-
-
-
Recent Advances in Nasopharyngeal Cancer Management: From Diagnosis to Theranostics
Nasopharyngeal cancer (NPC) is one of the most common head and neck cancers. NPC differs significantly from other cancers in its etiology, epidemiology, clinical behavior, and treatment. Being highly radiosensitive, the standard treatment for NPC is radiotherapy. However, radioresistance hampers the success of treatment and may cause local recurrence and distant metastases in NPC patients. In this revie Read More
-
-
-
Development of an Isothermal Point-of-care Genetic Rapid Test for the Detection of the HLA-B*57:01 Allele, a Predictor for Hypersensitivity Reaction Caused by Abacavir, for Stratifying Patients for Antiretroviral Abacavir HIV Therapy
Authors: Alexander E. Jacobsen, Antje Jüngling, Corinna Gorges and Moritz EidensBackground: Abacavir is used in the treatment of HIV-infected patients. A hypersensitive reaction (HSR) occurs in about 5-8% of patients treated with Abacavir. The HLA-B*57:01 allele is a valuable predictor for HSR and its screening is mandatory prior to treatment with Abacavir. Objective: Current screening methods require considerable investments for equipment. In order to lower the required investments and enable phy Read More
-
-
-
The Comparative Genomics and Network Analysis of eNOS by Using Different Bioinformatics Approaches
Background: Nitric oxide synthase (NOS) is an enzyme that catalyzes the synthesis of nitric oxide (NO) from L-arginine. It has three isoforms- (i) neuronal NOS (nNOS or NOS1), which participates in neural transmission; (ii) inducible NOS (iNOS or NOS2), which produces NO in macrophages; and (iii) endothelial NOS (eNOS or NOS3) that regulates blood pressure. The eNOS is mainly expressed in blood vessels and is a crucial r Read More
-
-
-
Riboflavin and Histidine Metabolisms Are Two Key Pathways Related to the Clinically Isolated Syndrome (CIS): A WGCNA-based In silico Analysis
Background: As an inflammatory disorder, Multiple Sclerosis (MS) causes demyelination, as well as axonal and neuronal injury in the central nervous system (CNS). Several clinical signs may be the indicators of MS among which, Clinically Isolated Syndrome (CIS) is the first symptom caused by the inflammation and demyelination of CNS. CIS is characterized by symptoms such as optic neuritis, brain stem or cerebellar Read More
-
Volumes & issues
Most Read This Month
Article
content/journals/cppm
Journal
10
5
false
en
